Home » Topics » Regulatory » Patents

Patents
RSS

CI-958 for treatment of prostate cancer

Sep. 20, 1996

SAMDC inhibitors from Ciba-Geigy

Sep. 20, 1996

Nitrogen mustard prodrugs from CRC Technology

Sep. 20, 1996

New formulation of ciclosporin

Sep. 20, 1996

University of Kentucky's PC-16 for arthritis

Sep. 20, 1996

Anti-HIV compounds from Janssen

Sep. 20, 1996

New tablet formulation of valaciclovir

Sep. 20, 1996

Antifungal cyclohexapeptides from Merck & Co.

Sep. 20, 1996

Antibacterial compositions for MRSA

Sep. 20, 1996

Amgen claims wound-healing growth factor

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...